Thus, our data support a model in which age-associated CD44 expression in hepatocytes contributes to a HCC-prone niche by fostering an IL6/JAK/STAT3-dependent immune suppressive microenvironment. The gene discussed is CD44; the disease is hepatocellular carcinoma.